Furthermore, with regard to the effects of GLP-1, the intraislet hypothesis is also inconsistent with the fact that GLP-1 retains the ability to inhibit glucagon secretion in individuals with type 1 diabetes with no residual beta cell population [9, 10]. The gene discussed is GCG; the disease is type 1 diabetes mellitus.